ym 09151-2 has been researched along with Dementia Praecox in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (60.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 2 (8.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dold, M; Kasper, S; Leucht, S; Li, C; Samara, MT; Tardy, M | 1 |
| Dean, B; Gray, L; Hannan, AJ; Scarr, E; van den Buuse, M | 1 |
| Bhardwaj, SK; Hamel, E; Hascalovici, J; Liberman, A; Lin, SH; Mui, J; Schipper, HM; Song, W; Srivastava, LK; Tavitian, A; Tong, XK; Vali, H; Zukor, H | 1 |
| Meltzer, HY; Overholser, JC; Stockmeier, CA; Sumiyoshi, T; Thompson, PA | 1 |
| Mason, SL; Reynolds, GP | 2 |
| Strange, PG; Vile, JM | 2 |
| Seeman, P; Van Tol, HH | 1 |
| Bigelow, LB; Carter, JM; Herman, MM; Hyde, TM; Kleinman, JE; Knable, MB; Murray, AM; Weinberger, DR | 1 |
| Guan, HC; Niznik, HB; Seeman, P; Van Tol, HH | 1 |
| Kubota, T | 1 |
| Guan, HC; Seeman, P; Van Tol, HH | 1 |
| Satoh, K; Shibasaki, M; Someya, T | 2 |
| Bunney, W; Fang, H; Helmeste, DM; Jones, EG; Li, M; Potkin, S; Tang, SW; Vu, R | 1 |
| Copolov, D; Hill, C; Keks, N; Marzella, PL; Singh, B | 1 |
| Ishida, M; Kaneko, S; Kondo, T; Otani, K; Tokinaga, N; Yasui, N | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Nagashima, U; Ono, S; Otani, K; Suzuki, A; Yasui, N | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Nagashima, U; Otani, K; Suzuki, A; Tanaka, O | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Nagashima, U; Ono, S; Otani, K; Suzuki, A | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Nagashima, U; Ohkubo, T; Ono, S; Osanai, T; Otani, K; Sugawara, K; Yasui, N | 1 |
| Kaneko, S; Kondo, T; Mihara, K; Ono, S; Otani, K; Suzuki, A; Yasui, N | 1 |
| Furukori, H; Inoue, Y; Ishida, M; Kaneko, S; Kondo, T; Mihara, K; Otani, K; Suzuki, A; Yasui-Furukori, N | 1 |
| Ishida, M; Kaneko, S; Kondo, T; Mihara, K; Ono, S; Tokinaga, N; Yasui-Furukori, N | 1 |
1 review(s) available for ym 09151-2 and Dementia Praecox
| Article | Year |
|---|---|
Are all first-generation antipsychotics equally effective in treating schizophrenia? A meta-analysis of randomised, haloperidol-controlled trials.
Topics: Antipsychotic Agents; Benzamides; Haloperidol; Humans; Publication Bias; Randomized Controlled Trials as Topic; Sample Size; Schizophrenia; Treatment Outcome | 2016 |
5 trial(s) available for ym 09151-2 and Dementia Praecox
| Article | Year |
|---|---|
Nemonapride for the treatment of schizophrenia.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Antipsychotic Agents; Benzamides; Hospitalization; Humans; Middle Aged; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 1997 |
Effects of nemonapride on positive and negative symptoms of schizophrenia.
Topics: Adult; Antipsychotic Agents; Benzamides; Female; Humans; Male; Middle Aged; Schizophrenia | 1996 |
No relationship between Taq1 a polymorphism of dopamine D(2) receptor gene and extrapyramidal adverse effects of selective dopamine D(2) antagonists, bromperidol, and nemonapride in schizophrenia: a preliminary study.
Topics: Acute Disease; Alleles; Antipsychotic Agents; Benzamides; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Extrapyramidal Tracts; Female; Haloperidol; Humans; Male; Pilot Projects; Polymorphism, Restriction Fragment Length; Receptors, Dopamine D2; Reproducibility of Results; Schizophrenia | 2000 |
Therapeutic spectrum of nemonapride and its relationship with plasma concentrations of the drug and prolactin.
Topics: Adolescent; Adult; Antipsychotic Agents; Benzamides; Biotransformation; Female; Humans; Male; Middle Aged; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Time Factors | 2000 |
No relationship between--141C Ins/Del polymorphism in the promoter region of dopamine D2 receptor and extrapyramidal adverse effects of selective dopamine D2 antagonists in schizophrenic patients: a preliminary study.
Topics: Adult; Benzamides; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia | 2001 |
19 other study(ies) available for ym 09151-2 and Dementia Praecox
| Article | Year |
|---|---|
Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.
Topics: Animals; Antipsychotic Agents; Autoradiography; Behavior, Animal; Benzamides; Clozapine; Excitatory Amino Acid Antagonists; Exploratory Behavior; Mice; Mice, Inbred C57BL; Mice, Knockout; Motor Activity; Muscarinic Antagonists; Radioligand Assay; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Reflex, Startle; Schizophrenia; Schizophrenic Psychology; Serotonin Antagonists; Up-Regulation | 2009 |
Schizophrenia-like features in transgenic mice overexpressing human HO-1 in the astrocytic compartment.
Topics: Acoustic Stimulation; Age Factors; alpha-Synuclein; Analysis of Variance; Animals; Animals, Newborn; Astrocytes; Benzamides; Benzazepines; Biogenic Monoamines; Brain; Chromatography, High Pressure Liquid; Disease Models, Animal; Dopamine Agents; Embryo, Mammalian; Enzyme-Linked Immunosorbent Assay; Gait Disorders, Neurologic; Gene Expression Regulation, Developmental; Glial Fibrillary Acidic Protein; Heme Oxygenase-1; Homeodomain Proteins; Humans; Inhibition, Psychological; Laser-Doppler Flowmetry; Mice; Mice, Transgenic; MicroRNAs; Nuclear Receptor Subfamily 4, Group A, Member 2; Protein Binding; Receptors, Dopamine D1; Receptors, Dopamine D2; Reelin Protein; RNA, Messenger; Schizophrenia; Sensory Gating; Superoxide Dismutase; Transcription Factors; Tritium; Tyrosine 3-Monooxygenase | 2012 |
Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression.
Topics: Adult; Aged; Aged, 80 and over; Benzamides; Caudate Nucleus; Depressive Disorder; Dopamine Antagonists; Female; GTP-Binding Proteins; Guanine Nucleotides; Guanylyl Imidodiphosphate; Humans; In Vitro Techniques; Kinetics; Male; Middle Aged; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides; Schizophrenia | 1995 |
Absence of detectable striatal dopamine D4 receptors in drug-treated schizophrenia.
Topics: Aged; Benzamides; Corpus Striatum; Dopamine Antagonists; Female; Humans; Male; Middle Aged; Putamen; Pyrrolidines; Receptors, Dopamine; Schizophrenia | 1995 |
D4 receptors and schizophrenia.
Topics: Benzamides; Binding, Competitive; Dopamine Antagonists; Humans; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides; Schizophrenia | 1995 |
Dopamine D4-like receptor elevation in schizophrenia: cloned D2 and D4 receptors cannot be discriminated by raclopride competition against [3H]nemonapride.
Topics: Animals; Benzamides; Binding, Competitive; Dopamine Antagonists; Humans; In Vitro Techniques; Raclopride; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Recombinant Proteins; Salicylamides; Schizophrenia | 1995 |
Distribution of putative D4 dopamine receptors in postmortem striatum from patients with schizophrenia.
Topics: Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzamides; Corpus Striatum; Female; Humans; Male; Mental Disorders; Middle Aged; Nucleus Accumbens; Raclopride; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Salicylamides; Schizophrenia; Suicide; Up-Regulation | 1995 |
Are striatal dopamine D4 receptors increased in schizophrenia?
Topics: Aged; Animals; Antipsychotic Agents; Benzamides; Binding, Competitive; Corpus Striatum; Dopamine D2 Receptor Antagonists; Humans; Kinetics; Pyrrolidines; Raclopride; Receptors, Dopamine; Receptors, Dopamine D4; Reference Values; Salicylamides; Schizophrenia | 1994 |
Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata.
Topics: Animals; Benzamides; Corpus Striatum; Dopamine D2 Receptor Antagonists; Humans; In Vitro Techniques; Kinetics; Parkinson Disease; Pituitary Gland, Anterior; Pyrrolidines; Raclopride; Rats; Receptors, Dopamine; Receptors, Dopamine D4; Salicylamides; Schizophrenia; Spiperone; Swine; Tomography, Emission-Computed | 1993 |
Neuroleptic malignant syndrome induced by nemonapride.
Topics: Adolescent; Benzamides; Female; Humans; Neuroleptic Malignant Syndrome; Pyrrolidines; Schizophrenia | 1993 |
Schizophrenia: elevation of dopamine D4-like sites, using [3H]nemonapride and [125I]epidepride.
Topics: Aged; Benzamides; Corpus Striatum; Female; Humans; Male; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Schizophrenia | 1995 |
D2-like dopamine receptors are not detectable on human peripheral blood lymphocytes.
Topics: Adult; Antipsychotic Agents; Benzamides; Binding, Competitive; Dopamine Antagonists; Female; Humans; Lymphocytes; Male; Polymerase Chain Reaction; Radioligand Assay; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Schizophrenia | 1996 |
Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains.
Topics: Adult; Aged; Benzamides; Brain Chemistry; Dopamine Antagonists; Humans; In Vitro Techniques; Kinetics; Male; Middle Aged; Raclopride; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Receptors, sigma; Salicylamides; Schizophrenia | 1997 |
The binding of both [3H]nemonapride and [3H]raclopride is increased in schizophrenia.
Topics: Adult; Aged; Antipsychotic Agents; Autoradiography; Benzamides; Caudate Nucleus; Cerebral Cortex; Female; Humans; Male; Middle Aged; Putamen; Raclopride; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Dopamine D4; Reference Values; Salicylamides; Schizophrenia | 1997 |
Characteristics and risk factors of acute dystonia in schizophrenic patients treated with nemonapride, a selective dopamine antagonist.
Topics: Acute Disease; Adolescent; Adult; Benzamides; Dopamine Antagonists; Dystonia; Female; Humans; Male; Middle Aged; Prolactin; Prospective Studies; Risk Factors; Schizophrenia; Sex Characteristics | 1999 |
Prolactin response to nemonapride, a selective antagonist for D2 like dopamine receptors, in schizophrenic patients in relation to Taq1A polymorphism of DRD2 gene.
Topics: Adolescent; Adult; Alleles; Benzamides; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Female; Humans; Male; Middle Aged; Polymorphism, Restriction Fragment Length; Prolactin; Receptors, Dopamine D2; Schizophrenia; Sex Factors | 2000 |
The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Benzamides; Dopamine Antagonists; Female; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia; Taq Polymerase | 2000 |
The -141C Ins/Del polymorphism in the dopamine D2 receptor gene promoter region is associated with anxiolytic and antidepressive effects during treatment with dopamine antagonists in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Anxiety; Benzamides; Depression; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Middle Aged; Polymorphism, Genetic; Receptors, Dopamine D2; Schizophrenia | 2001 |
Associations between side effects of nemonapride and plasma concentrations of the drug and prolactin.
Topics: Adolescent; Adult; Antipsychotic Agents; Basal Ganglia Diseases; Benzamides; Female; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Statistics, Nonparametric | 2002 |